Glenmede Trust’s CryoPort CYRX Stock Holding History

Glenmede Trust’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8,804	Closed	-$211K	–	1289
2023 Q2	$211K	Hold	8,804	–	–	﹤0.01%	1089
2023 Q1	$211K	Sell	8,804 -4,719	-35%	-$103K	﹤0.01%	1094
2022 Q4	$235K	Sell	13,523 -381	-3%	-$8.03K	﹤0.01%	1053
2022 Q3	$338K	Sell	13,904 -7,104	-34%	-$245K	﹤0.01%	915
2022 Q2	$650K	Buy	21,008 +5,997	+40%	+$160K	﹤0.01%	782
2022 Q1	$524K	Buy	15,011 +2,970	+25%	+$112K	﹤0.01%	882
2021 Q4	$712K	Sell	12,041 -5,405	-31%	-$374K	﹤0.01%	833
2021 Q3	$1.16M	Sell	17,446 -2,492	-12%	-$154K	0.01%	661
2021 Q2	$1.26M	Sell	19,938 -2,579	-11%	-$145K	0.01%	642
2021 Q1	$1.17M	Buy	22,517 +307	+1%	+$18.7K	0.01%	644
2020 Q4	$974K	Buy	+22,210	New	+$1.06M	0.01%	672

Other funds holding CYRX

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Glenmede Trust's CYRX Position: Q3 2023 in Review

Glenmede Trust sold out of CryoPort (CYRX) in Q3 2023, closing a stake of 8,804 shares — an estimated $211K sold.

Glenmede Trust first reported a position in CYRX in Q4 2020 and held it in 11 quarters. The position peaked at $1.26M in Q2 2021. 158 funds tracked by Wall St. Rank hold CYRX as of Q3 2023.

Glenmede Trust reported no remaining CryoPort position as of Q3 2023 after selling out during the quarter.
Glenmede Trust sold 8,804 CryoPort shares in Q3 2023, an estimated $211K.
Glenmede Trust first reported a position in CryoPort in Q4 2020 and held it in 11 quarters.
Glenmede Trust's CryoPort position peaked at $1.26M in Q2 2021.
158 funds tracked by Wall St. Rank held CryoPort as of Q3 2023.

Based on Glenmede Trust's 13F filing for Q3 2023, filed 14 Nov 2023.